ReviewMicroorganisms2026
Microbe-Derived Antimicrobial Peptides: Immunomodulation and Gut Microbiota Homeostasis.
Review in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Antimicrobial peptides (AMPs) are key components of the innate immune system across a wide range of organisms. In addition to their direct antimicrobial activity, AMPs exert immunomodulatory effects that differ from those of conventional antibiotics. This review summarizes recent evidence on the roles of microbe-derived AMPs in regulating immune cell function, including neutrophil activation and NET formation, macrophage polarization, and lymphocyte proliferation and differentiation. It also examines their organ-specific roles, particularly in intestinal immunity through reinforcement of the intestinal barrier, maintenance of gut microbiota homeostasis, and promotion of sIgA secretion. Together, their direct antimicrobial and immunomodulatory activities support the therapeutic potential of microbe-derived AMPs against drug-resistant infections, cancer, and inflammatory conditions. We synthesize recent evidence on the modulation of innate and adaptive immunity by microbe-derived AMPs. This review provides an integrated framework for understanding how microbe-derived AMPs orchestrate immune defense across cellular, tissue, and systemic levels, with implications for therapeutic development against infectious, inflammatory, and neoplastic diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.